Institutional Ownership Cv Rx, Inc. (CVRX)
This table provides information about the institutional ownership of Cv Rx, Inc. (CVRX). We have compiled data on the 95 institutions that hold shares in the stock, with a total of 15.6 Million shares, which have been reported (via 13F filing form) to have a value of $117 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Johnson & Johnson
New Brunswick, NJ |
Jul 22, 2025 Q2 2025 |
4,103,430
shares
|
$30.8 Million
8.12% of portfolio
|
Q1 2024
Added 17.39%
|
|
Nea Management Company, LLC
Timonium, MD |
May 14, 2025 Q1 2025 |
2,026,083
shares
|
$15.2 Million
2.35% of portfolio
|
Q4 2024
Reduced 14.53%
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
1,229,522
shares
|
$9.23 Million
1.95% of portfolio
|
Q1 2025
Added 33.47%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
1,077,278
shares
|
$8.09 Million
0.0% of portfolio
|
Q2 2025
Added 7.01%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
875,753
shares
|
$6.58 Million
0.0% of portfolio
|
Q2 2024
Added 14.48%
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
407,622
shares
|
$3.06 Million
0.01% of portfolio
|
Q1 2025
Added 18.44%
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
May 13, 2025 Q1 2025 |
396,763
shares
|
$2.98 Million
0.02% of portfolio
|
Q1 2025
New holding
|
|
Parian Global Management LP
Pound Ridge, NY |
Nov 14, 2022 Q3 2022 |
393,227
shares
|
$2.95 Million
11.93% of portfolio
|
Q3 2022
Reduced 25.87%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
382,437
shares
|
$2.87 Million
0.0% of portfolio
|
Q2 2025
Added 6.42%
|
|
Silvercrest Asset Management Group LLC
New York, NY |
May 15, 2025 Q1 2025 |
369,831
shares
|
$2.78 Million
0.03% of portfolio
|
Q1 2025
Reduced 0.57%
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
350,080
shares
|
$2.63 Million
0.0% of portfolio
|
Q2 2025
Added 238.14%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
325,389
shares
|
$2.44 Million
0.0% of portfolio
|
Q1 2025
Reduced 19.66%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
293,274
shares
|
$2.2 Million
0.0% of portfolio
|
Q1 2025
Added 6.24%
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
263,682
shares
|
$1.98 Million
0.11% of portfolio
|
Q2 2025
Added 377.68%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
255,043
shares
|
$1.92 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
253,122
shares
|
$1.9 Million
0.02% of portfolio
|
Q1 2025
Reduced 9.38%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
199,005
shares
|
$1.49 Million
0.0% of portfolio
|
Q1 2025
Reduced 7.5%
|
|
Archon Capital Management LLC
Seattle, WA |
Aug 13, 2025 Q2 2025 |
175,000
shares
|
$1.31 Million
0.96% of portfolio
|
Q2 2025
Reduced 30.46%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
158,399
shares
|
$1.19 Million
0.0% of portfolio
|
Q4 2024
Reduced 24.62%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
148,384
shares
|
$1.11 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.41%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
147,128
shares
|
$1.1 Million
0.0% of portfolio
|
Q1 2025
Added 165.73%
|
|
Mairs & Power Inc
St Paul, MN |
May 15, 2025 Q1 2025 |
144,281
shares
|
$1.08 Million
0.02% of portfolio
|
Q4 2024
Reduced 0.06%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
126,906
shares
|
$953,064
0.0% of portfolio
|
Q1 2025
Reduced 13.4%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
124,959
shares
|
$938,442
0.0% of portfolio
|
Q1 2025
Reduced 80.11%
|
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
May 15, 2025 Q1 2025 |
118,026
shares
|
$886,375
0.0% of portfolio
|
Q1 2025
Added 55.53%
|